Head-to-head clinical analysis & difference comparison: details on mechanism of action, dosing, half-life, interactions, and maternal-fetal safety.
AMPICILLIN AND SULBACTAM vs AMOXICILLIN
Head-to-head clinical comparison of therapeutic indices and safety profiles.
Ampicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity. Sulbactam is a β-lactamase inhibitor that irreversibly inhibits a broad range of β-lactamases, preventing degradation of ampicillin.
Amoxicillin is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity, and activating autolytic enzymes.
Skin and skin structure infections,Intra-abdominal infections,Gynecological infections,Community-acquired pneumonia (in combination with other agents),Off-label: diabetic foot infections, aspiration pneumonia, febrile neutropenia
Upper respiratory tract infections (e.g., otitis media, sinusitis, pharyngitis/tonsillitis),Lower respiratory tract infections (e.g., community-acquired pneumonia, acute exacerbation of chronic bronchitis),Genitourinary tract infections (e.g., cystitis, urethritis),Skin and skin structure infections,Helicobacter pylori eradication (in combination with clarithromycin and a proton pump inhibitor),Lyme disease (early localized),Prophylaxis of infective endocarditis (for dental procedures in high-risk patients),Off-label: Anthrax (post-exposure prophylaxis), uncomplicated gonorrhea
1.5-3 g (ampicillin 1-2 g + sulbactam 0.5-1 g) IV/IM every 6 hours. Maximum daily dose of sulbactam is 4 g.
250-500 mg orally every 8 hours or 500-875 mg orally every 12 hours; for severe infections, up to 1 g orally every 8 hours.
Ampicillin: 1-1.8 hours; sulbactam: 1-1.5 hours. Prolonged in renal impairment (e.g., creatinine clearance <30 m L/min: up to 8-12 hours).
Terminal elimination half-life: 1-1.5 hours in normal renal function. Prolonged to 7-20 hours in end-stage renal disease.
Ampicillin undergoes minimal hepatic metabolism; primarily excreted unchanged in urine via renal tubular secretion. Sulbactam is primarily excreted unchanged in urine with minimal metabolism.
Cr Cl >30 m L/min: no adjustment. Cr Cl 15-30 m L/min: dose every 12 hours. Cr Cl 5-15 m L/min: dose every 24 hours. Cr Cl <5 m L/min: dose every 48 hours. Hemodialysis: administer after dialysis.
Cr Cl 30-50 m L/min: 250-500 mg every 8-12 hours. Cr Cl 10-29 m L/min: 250-500 mg every 12 hours. Cr Cl <10 m L/min: 250-500 mg every 24 hours. Hemodialysis: 250-500 mg every 24 hours, supplemented during and after dialysis.
No FDA black box warning.
FDA Pregnancy Category B. Animal studies show no fetal harm; no adequate human studies. Crosses placenta. No known teratogenicity in first trimester; theoretical risk of kernicterus in third trimester due to bilirubin displacement at high doses is negligible with sulbactam.
FDA Pregnancy Category B. No evidence of teratogenicity in animal studies. First trimester: no increased risk of major malformations observed in large cohort studies. Second and third trimesters: use only if clearly needed; no known fetal harm, but caution due to maternal physiological changes.
Ampicillin-sulbactam covers MSSA, Streptococcus spp., Enterococcus faecalis, anaerobes (including B. fragilis), and many Enterobacteriaceae. It does not cover MRSA, Pseudomonas, or ESBL-producing organisms. Sulbactam irreversibly inhibits beta-lactamases but does not restore activity against Acinetobacter due to intrinsic resistance. Dose adjustment required for Cr Cl <30 m L/min (extend interval to q12h). Administer within 1 hour of reconstitution due to degradation. Monitor for diarrhea, as C. difficile infection is common.
For streptococcal pharyngitis, amoxicillin 50 mg/kg once daily (max 1 g) is as effective as multiple daily doses and improves adherence. In penicillin-allergic patients, the cross-reactivity risk with cephalosporins is low; a cephalosporin can be used if no history of immediate-type hypersensitivity. Amoxicillin is not effective against penicillinase-producing staphylococci or most Gram-negative organisms due to beta-lactamase production. Monitor for rash in patients with infectious mononucleosis (ampicillin rash occurs more frequently, but amoxicillin also has increased risk). Dose adjustment needed for creatinine clearance <30 m L/min.
No interactions on record
"The metabolism of Voriconazole can be decreased when combined with Amoxicillin."
"The metabolism of Fluvoxamine can be decreased when combined with Amoxicillin."
"The metabolism of Rucaparib can be decreased when combined with Amoxicillin."
AMPICILLIN AND SULBACTAM and AMOXICILLIN are distinct pharmacological agents. AMPICILLIN AND SULBACTAM belongs to the Penicillin Antibiotic class and is primarily used for Skin and skin structure infectionsIntra-abdominal infectionsGynecological infectionsCommunity-acquired pneumonia (in combination with other agents)Off-label: diabetic foot infections, aspiration pneumonia, febrile neutropenia. AMOXICILLIN belongs to the Penicillin Antibiotic class and is primarily used for Upper respiratory tract infections (e.g., otitis media, sinusitis, pharyngitis/tonsillitis)Lower respiratory tract infections (e.g., community-acquired pneumonia, acute exacerbation of chronic bronchitis)Genitourinary tract infections (e.g., cystitis, urethritis)Skin and skin structure infectionsHelicobacter pylori eradication (in combination with clarithromycin and a proton pump inhibitor)Lyme disease (early localized)Prophylaxis of infective endocarditis (for dental procedures in high-risk patients)Off-label: Anthrax (post-exposure prophylaxis), uncomplicated gonorrhea. Their specific mechanisms of action, pharmacokinetic characteristics, and side effects differ.
The maternal-fetal safety profiles of these drugs differ. AMPICILLIN AND SULBACTAM carries a safety status of Category A/B, whereas AMOXICILLIN safety is classified as Category A/B. Consult a board-certified physician or healthcare specialist to establish an accurate, individualized pregnancy risk assessment before starting either therapy.
Amoxicillin is primarily metabolized by hydrolysis to penicilloic acid (inactive). It is not extensively metabolized by the liver; about 60% of an oral dose is excreted unchanged in urine.
Primarily renal (70-75% unchanged ampicillin, 75-80% unchanged sulbactam). Biliary excretion accounts for ~25% of ampicillin and ~20% of sulbactam. Fecal elimination is minor (<5%).
Renal: 60-80% unchanged via glomerular filtration and tubular secretion. Biliary: up to 20% excreted in bile. Fecal: minimal.
Ampicillin: 15-25% to albumin; sulbactam: 38% to albumin.
17-20% bound to serum albumin.
Ampicillin: 0.28 L/kg; sulbactam: 0.24 L/kg. Distributes well into extracellular fluid, bile, and inflamed tissues, but limited CNS penetration unless meninges inflamed.
0.3-0.4 L/kg. Distributes well into most body fluids and tissues, including pleural, peritoneal, and synovial fluids; limited CNS penetration unless meninges inflamed.
IV: 100%; IM: ~80% for both components (peak serum concentrations reached 30-60 min after IM injection). Oral ampicillin alone ~30-55% but fixed combination not available orally.
Oral: 74-92% (absorption is not food-dependent). IM: approximately 100%.
No dose adjustment required for hepatic impairment. Monitor for toxicity in severe hepatic failure.
No dose adjustment required for mild to moderate hepatic impairment. Severe hepatic impairment (Child-Pugh class C): use with caution; specific dosing guidelines not established.
Neonates <1 week: 75 mg/kg/day (ampicillin 50 mg/kg + sulbactam 25 mg/kg) IV divided every 12 hours. Neonates 1-4 weeks: 150 mg/kg/day divided every 8 hours. Infants/children: 200-400 mg/kg/day (ampicillin 150-300 mg/kg) IV divided every 6 hours; maximum sulbactam 80 mg/kg/day.
Children >3 months: 20-40 mg/kg/day divided every 8 hours for mild to moderate infections; 40-90 mg/kg/day divided every 8-12 hours for severe infections. Maximum 3 g/day.
No specific dose adjustment based on age alone; adjust per renal function. Consider lower initial doses due to age-related decline in renal function.
No specific dose adjustment; monitor renal function and adjust based on Cr Cl. Caution with concurrent nephrotoxic agents.
No FDA black box warning.
No significant food interactions. Ampicillin-sulbactam can be taken with or without food; however, food may decrease absorption slightly but not sufficient to require separation. Avoid alcohol due to potential disulfiram-like reaction (rare with penicillins). Maintain adequate hydration.
No significant food interactions. Absorption is not affected by food; may be taken with meals to reduce gastrointestinal upset. Avoid concurrent alcohol consumption as it may increase risk of side effects like nausea and vomiting.
Excreted into breast milk in low concentrations (M/P ratio ~0.05 for ampicillin, sulbactam data limited). Considered compatible with breastfeeding; monitor infant for diarrhea, rash, or candidiasis.
Amoxicillin is excreted into breast milk in small amounts (M/P ratio approximately 0.014-0.015). Considered compatible with breastfeeding; potential for diarrhea or allergic sensitization in infant, but generally safe.
Increased renal clearance in pregnancy may lower serum concentrations; consider standard dosing but monitor for therapeutic efficacy. No specific dose adjustment recommended unless renal impairment present.
No dose adjustment required for amoxicillin in pregnancy; however, increased renal clearance and expanded plasma volume may lower serum concentrations. For severe infections, consider standard dosing with monitoring of clinical response.
Take this medication exactly as prescribed; do not skip doses.,Complete the full course even if you feel better.,Notify your doctor if you experience severe diarrhea, rash, or difficulty breathing.,This medication may cause diarrhea; if it is watery or bloody, contact your doctor immediately.,Inform your healthcare provider of all other medications you are taking, especially warfarin or methotrexate.
Take exactly as prescribed; complete the full course even if you feel better.,Can be taken with or without food; if stomach upset occurs, take with a meal.,Swallow capsules whole; do not crush or chew; oral suspension shake well before each dose.,Skip missed dose if almost time for next; do not double dose.,Seek immediate medical help for signs of allergic reaction: hives, difficulty breathing, swelling of face/lips/tongue.,May cause diarrhea; contact doctor if watery or bloody stools.,Inform doctor if you are pregnant, planning to become pregnant, or breastfeeding.,Avoid large amounts of grapefruit juice as it may affect absorption (limited clinical significance).